{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T04:42:06Z","timestamp":1770957726534,"version":"3.50.1"},"reference-count":40,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Sci. OA"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.2144\/fsoa-2019-0064","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T12:31:43Z","timestamp":1574771503000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Battle of Thermopylae: 300 Spartans (natural Killer Cells Plus obinutuzumab) Versus the Immortal Warriors (chronic Lymphocytic Leukemia cells) of Xerxes\u2019 Army"],"prefix":"10.1080","volume":"5","author":[{"given":"Ricardo","family":"Garc\u00eda-Mu\u00f1oz","sequence":"first","affiliation":[{"name":"Department of Hematology, San Pedro Hospital, 26006 Logro\u00f1o, La Rioja, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda-Josefa","family":"N\u00e1jera","sequence":"additional","affiliation":[{"name":"Department of Hematology, San Pedro Hospital, 26006 Logro\u00f1o, La Rioja, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Feliu","sequence":"additional","affiliation":[{"name":"Department of Hematology, San Pedro Hospital, 26006 Logro\u00f1o, La Rioja, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Ant\u00f3n-Rem\u00edrez","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine & Rehabilitation, Navarra Hospital Complex, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Ramalle-G\u00f3mara","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, La Rioja Regional Authority, Logro\u00f1o, La Rioja, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Mar\u00edn-Gorricho","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, San Pedro Hospital, Logro\u00f1o, La Rioja, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raisa","family":"Peralta","sequence":"additional","affiliation":[{"name":"Department of Hematology, San Pedro Hospital, 26006 Logro\u00f1o, La Rioja, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Guti\u00e9rrez-Gamarra","sequence":"additional","affiliation":[{"name":"Department of Hematology, Poniente Hospital, Almer\u00eda, Andaluc\u00eda, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Nu\u00f1ez-Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, San Pedro Hospital, Logro\u00f1o, La Rioja, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Zafra-Morales","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, San Pedro Hospital, Logro\u00f1o, La Rioja, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorea","family":"Aguinaga","sequence":"additional","affiliation":[{"name":"Department of Hematology, Centre Hospitalier Universitaire (CHU), Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda-Jose","family":"Nebot-Villacampa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, San Pedro Hospital, Logro\u00f1o, La Rioja, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prisma-Monserrat","family":"Hernandez-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Department of Hematology, San Pedro Hospital, 26006 Logro\u00f1o, La Rioja, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Farf\u00e1n-Quiroga","sequence":"additional","affiliation":[{"name":"Department of Hematology, San Pedro Hospital, 26006 Logro\u00f1o, La Rioja, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Panizo","sequence":"additional","affiliation":[{"name":"Hematology Department, University Clinic of Navarra, Pamplona, Navarra, Spain. Lymphoproliferative Group, Navarran Institute for Health Research (IDISNA), Pamplona, Navarra, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Dom\u00ednguez-Garrido","sequence":"additional","affiliation":[{"name":"Molecular Diagnostic Unit, Rioja Health Foundation, Logro\u00f1o, La Rioja, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"e_1_3_5_2_1","volume-title":"1001 Battles that Changed the Course of History (Spanish Edition).","author":"Grant RG","year":"1999","unstructured":"GrantRG , DoughtyR. 1001 Battles that Changed the Course of History (Spanish Edition).Mart\u00ednezRoca (Ed.). Ilustrados Grijalbo Lumen, Barcelona, Spain (1999)."},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-225979"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-12-1182"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614598"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313984"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.2139"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-670802"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2017-0147"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-015-8747-9"},{"key":"e_1_3_5_11_1","unstructured":"ClinicalTrials.gov. MabRella study: a study to evaluate the safety of switching from intravenous to subcutaneous administration of rituximab during first line treatment for lymphoma (NCT01987505) (2018). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01987505"},{"key":"e_1_3_5_12_1","unstructured":"ClinicalTrials.gov. Rituximab and autologous effector lymphocytes in non-Hodgkin follicular lymphoma in response to first line chemotherapy (NCT01329354) (2017). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01329354"},{"key":"e_1_3_5_13_1","unstructured":"Social Science Statistics (2019). http:\/\/www.socscistatistics.com"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30078-9"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)00004-1"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.2631"},{"key":"e_1_3_5_17_1","volume-title":"Cuentos Completos 2 (Spanish Edition).","author":"Grimm J","year":"2019","unstructured":"GrimmJ , GrimmW. Cuentos Completos 2 (Spanish Edition).Alianza Editorial, Madrid, Spain (2019)."},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.33_2630"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-019-0141-1"},{"key":"e_1_3_5_20_1","first-page":"215","volume-title":"Clinical Immunology. Principles and Practice (4th Edition).","author":"Nutt SL","year":"2013","unstructured":"NuttSL , CarottaS , KalliesA , BetzGT. Cytotoxic T lymphocytes and natural killer cells. In: Clinical Immunology. Principles and Practice (4th Edition).RichRR, FleisherTA, ShearerWT, SchoroederHW, FrewAJ, WeilandCM (Eds). Elsevier Sauders, PA, USA, 215\u2013277 (2013)."},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3270"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1351"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0158"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-839688"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30788-5"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713976"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1815281"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2439_148"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000289"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.148"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.7551\/mitpress\/10815.001.0001"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.192_2631"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018029371"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.07.038"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.4.2916"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701122"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000029993"},{"issue":"7","key":"e_1_3_5_38_1","first-page":"2427","article-title":"Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug","volume":"118","author":"Ramsay AG","year":"2008","unstructured":"RamsayAG , JohnsonAJ , LeeAMet al.Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J. Clin. Invest.118(7), 2427\u20132437 (2008).","journal-title":"J. Clin. Invest."},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-411678"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23170"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290017033"}],"container-title":["Future Science OA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2144\/fsoa-2019-0064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:49:06Z","timestamp":1719125346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2144\/fsoa-2019-0064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.2144\/fsoa-2019-0064"],"URL":"https:\/\/doi.org\/10.2144\/fsoa-2019-0064","relation":{},"ISSN":["2056-5623"],"issn-type":[{"value":"2056-5623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifso20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifso20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-06-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"FSO425"}}